Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation (2017)
Source: Cell Biology and Toxicology. Unidades: FEARP, FCFRP, FMRP
Subjects: DIFERENCIAÇÃO CELULAR, CÉLULAS-TRONCO, CÉLULAS SANGUÍNEAS, PATENTE
ABNT
PAES, Bárbara Cristina Martins Fernandes et al. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation. Cell Biology and Toxicology, v. 33, n. 3, p. 233-250, 2017Tradução . . Disponível em: https://doi.org/10.1007/s10565-016-9377-2. Acesso em: 08 set. 2024.APA
Paes, B. C. M. F., Moço, P. D., Pereira, C. G., Porto, G. S., Russo, E. M. de S., Reis, L. C. J., et al. (2017). Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation. Cell Biology and Toxicology, 33( 3), 233-250. doi:10.1007/s10565-016-9377-2NLM
Paes BCMF, Moço PD, Pereira CG, Porto GS, Russo EM de S, Reis LCJ, Covas DT, Picanço-Castro V. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation [Internet]. Cell Biology and Toxicology. 2017 ; 33( 3): 233-250.[citado 2024 set. 08 ] Available from: https://doi.org/10.1007/s10565-016-9377-2Vancouver
Paes BCMF, Moço PD, Pereira CG, Porto GS, Russo EM de S, Reis LCJ, Covas DT, Picanço-Castro V. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation [Internet]. Cell Biology and Toxicology. 2017 ; 33( 3): 233-250.[citado 2024 set. 08 ] Available from: https://doi.org/10.1007/s10565-016-9377-2